Clinical Trial: The Adaptive Platform Trial for Kidney Disease

U.S., May 20 -- ClinicalTrials.gov registry received information related to the study (NCT07595952) titled 'The Adaptive Platform Trial for Kidney Disease' on May 12.

Brief Summary: Background: Randomized clinical trials (RCTs) are essential for evaluating intervention effects but are often challenged by regulatory and logistical burdens, high costs, and extended timelines. To address these challenges, the 'Adaptive Platform Trial in Kidney Disease' (APT-KIDNEY) will establish an investigator-initiated platform trial built on a unified regulatory, contractual, and operational framework. The platform emphasizes adaptive, cost-efficient methodology, automated data capture via linkage to electronic health records and administrative registers,...